Steveporshe. the next few years will be a little different than the last few years, when it comes to financing, I can assure you. DNDN has a potential blockbuster drug. I've never heard of a secondary in the $3 range, especially after they blew the money they got at $6. thats why I'm asking. If its been done before, then I'm wrong. Does anyone have any other examples of successful secondaries in the $3 range?
News 
Market Data 
Discover 
